Search Results - "Saunders, Hugo"

The prognostic significance of immune microenvironment in breast ductal carcinoma in situ by Toss, Michael S., Abidi, Asima, Lesche, Dorothea, Joseph, Chitra, Mahale, Sakshi, Saunders, Hugo, Kader, Tanjina, Miligy, Islam M., Green, Andrew R., Gorringe, Kylie L., Rakha, Emad A.

“…Background The role of different subtypes of tumour infiltrating lymphocytes (TILs) in breast ductal carcinoma in situ (DCIS) is still poorly defined. This…”
Get full text

Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand by Rajadevan, Niveditha, Flinkier, Ariane, Saunders, Hugo, Lee, Yeh Chen, Scott, Clare, Khaw, Pearly, Allan, Prue, Davies, Claire, Andrews, John, Wilson, Michelle, Lombard, Janine M, Harrison, Michelle, Nesfield, Heshani, DeFazio, Anna, Meniawy, Tarek, Gorringe, Kylie L

“…Mucinous ovarian carcinoma (MOC) is a rare ovarian cancer with limited evidence to support clinical care. We undertook a clinician survey to better understand…”
Get full text

Therapeutic options for mucinous ovarian carcinoma by Gorringe, Kylie L., Cheasley, Dane, Wakefield, Matthew J., Ryland, Georgina L., Allan, Prue E., Alsop, Kathryn, Amarasinghe, Kaushalya C., Ananda, Sumitra, Bowtell, David D.L., Christie, Michael, Chiew, Yoke-Eng, Churchman, Michael, DeFazio, Anna, Fereday, Sian, Gilks, C. Blake, Gourley, Charlie, Hadley, Alison M., Hendley, Joy, Hunter, Sally M., Kaufmann, Scott H., Kennedy, Catherine J., Köbel, Martin, Le Page, Cecile, Li, Jason, Lupat, Richard, McNally, Orla M., McAlpine, Jessica N., Pyman, Jan, Rowley, Simone M., Salazar, Carolina, Saunders, Hugo, Semple, Timothy, Stephens, Andrew N., Thio, Niko, Torres, Michelle C., Traficante, Nadia, Zethoven, Magnus, Antill, Yoland C., Campbell, Ian G., Scott, Clare L.

“…Mucinous ovarian carcinoma (MOC) is an uncommon ovarian cancer histotype that responds poorly to conventional chemotherapy regimens. Although long overall…”
Get full text

Abstract P6-10-21: Evaluation of genomic changes in ductal carcinoma in situ as potential biomarkers of recurrence risk by Lesche, Dorothea, Saunders, Hugo, Mahale, Sakshi, Zenthoven, Magnus, Huges, Siobhan, Kader, Tanjina, Thio, Niko, Miligy, Islam M, Pang, Jia-Min, Green, Andrew R, Rakha, Emad A, Campbell, Ian G, Fox, Stephen B, Gorringe, Kylie

“…Abstract Routine breast cancer screening has increased detection of pre-invasive lesions such as ductal carcinoma in situ (DCIS). Currently, DCIS cases are…”
Get full text

Molecular comparison of interval and screen‐detected breast cancers by Cheasley, Dane, Li, Na, Rowley, Simone M, Elder, Kenneth, Mann, G Bruce, Loi, Sherene, Savas, Peter, Goode, David L, Kader, Tanjina, Zethoven, Magnus, Semple, Tim, Fox, Stephen B, Pang, Jia‐Min, Byrne, David, Devereux, Lisa, Nickson, Carolyn, Procopio, Pietro, Lee, Grant, Hughes, Siobhan, Saunders, Hugo, Fujihara, Kenji M, Kuykhoven, Keilly, Connaughton, Jacquie, James, Paul A, Gorringe, Kylie L, Campbell, Ian G

“…Breast cancer (BC) diagnosed after a negative mammogram but prior to the next screening episode is termed an 'interval BC' (IBC). Understanding the molecular…”
Get full text

Abstract 43: Predictive biomarkers of recurrence may not be useful for deescalating treatment of breast ductal carcinoma in situ due to de novo ipsilateral breast carcinoma development by Kader, Tanjina, Mahale, Sakshi, Zethoven, Magnus, Saunders, Hugo, Lesche, Dorothea, Byrne, David, Lai, Siqi, Tjoeka, Lauren, Candido, Claire, Pechlevanis, Maree, Craig, Olivia, Pang, Jia-Min, Devereux, Lisa, Hendry, Shona, House, Eloise, Jayasinghe, Sureshni, Toss, Michael, Miligy, Islam M., Rakha, Emad, Fox, Stephen, Mann, Bruce, Campbell, Ian, Gorringe, Kylie

“…Abstract Introduction: Up to 25% of cases of ductal carcinoma in situ (DCIS) recur, and half of these recur as invasive breast cancer (IBC). There is no…”
Get full text

The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density by Cheasley, Dane, Devereux, Lisa, Hughes, Siobhan, Nickson, Carolyn, Procopio, Pietro, Lee, Grant, Li, Na, Pridmore, Vicki, Elder, Kenneth, Bruce Mann, G., Kader, Tanjina, Rowley, Simone M., Fox, Stephen B., Byrne, David, Saunders, Hugo, Fujihara, Kenji M., Lim, Belle, Gorringe, Kylie L., Campbell, Ian G.

“…Mammographic density (MD) influences breast cancer risk, but how this is mediated is unknown. Molecular differences between breast cancers arising in the…”
Get full text

The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density by Cheasley, Dane, Devereux, Lisa, Hughes, Siobhan, Nickson, Carolyn, Procopio, Pietro, Lee, Grant, Li, Na, Pridmore, Vicki, Elder, Kenneth, Bruce Mann, G, Kader, Tanjina, Rowley, Simone M, Fox, Stephen B, Byrne, David, Saunders, Hugo, Fujihara, Kenji M, Lim, Belle, Gorringe, Kylie L, Campbell, Ian G

“…Mammographic density (MD) influences breast cancer risk, but how this is mediated is unknown. Molecular differences between breast cancers arising in the…”
Get full text